Part B practices will have 16 new tests that you'll be able to report as "CLIA-waived," thanks to a Feb. 11 CMS transmittal on the matter. According to MLN Matters article MM7266, CMS will now consider these tests CLIA-waived. You'll have to append modifier QW (CLIA-waived test) to these codes, which include the following, among others: 87880 -- BTNX, Inc. Strep A Rapid Test 86308 -- Consult Diagnostics Mononucleosis Cassette (Whole Blood) 82274 and G0328 -- BTNX, Inc. Rapid Response Fecal Immunochemical Test G0434 -- Amedica Biotech AmediCheck Instant Test Cup G0434 -- On the Spot Drug Testing Multi-Drug of Abuse Urine Test To read the complete list of new CLIA-waived tests, visit
www.cms.gov/MLNMattersArticles/Downloads/MM7266.pdf. HHAs looking to avoid compliance problems sparked by a congressional therapy investigation of publicly traded home care companies have a new resource: the Delta Excellence in Therapy Report. The report is based on the Delta National Excellence in Therapy Forum, [...]
